M Hopman-Rock1, P G Staats, E C Tak, R M Dröes. 1. Department of Public Health and Prevention, TNO Prevention and Health, Leiden, The Netherlands. M.Hopman@pg.tno.nl
Abstract
OBJECTIVES: To test the effects of the Psychomotor Activation Programme (PAP) on the behaviour and cognition of demented elderly people. DESIGN: Randomized controlled trial with an experimental group and a control group. Post-test after 6 months. SETTING: Group care projects for demented elderly people living in 11 different homes for the elderly in The Netherlands. PARTICIPANTS: One hundred and thirty-four subjects entered the study (72 in the experimental group and 62 in the control group), 42 of whom dropped out (27 in the experimental group and 15 in the control group). MEASUREMENTS: Individual behaviour and group behaviour were scored using two Dutch scales (BIP and SIPO respectively) developed and validated for use in psychogeriatric populations. Cognition was measured with the short and the long versions of the Cognitive Screening Test (CST-14 and CST-20). Disability was measured with the Barthel Index. Medicine use, falls, other accidents and life events were registered. RESULTS: The PAP had a beneficial effect on cognition (CST-14, F = 2.63, p < or = 0.05, effect size 0.4) (CST-20, F = 3.77, p < or = 0.05, effect size 0.5) and increased positive group behaviour in participants with relatively mild cognitive problems (SIPO, F = 4.46 p < or = 0.05). CONCLUSIONS: The PAP stabilizes cognitive performance and has some beneficial effects on behaviour. Positive findings were supported by a simultaneously conducted process evaluation.
RCT Entities:
OBJECTIVES: To test the effects of the Psychomotor Activation Programme (PAP) on the behaviour and cognition of demented elderly people. DESIGN: Randomized controlled trial with an experimental group and a control group. Post-test after 6 months. SETTING: Group care projects for demented elderly people living in 11 different homes for the elderly in The Netherlands. PARTICIPANTS: One hundred and thirty-four subjects entered the study (72 in the experimental group and 62 in the control group), 42 of whom dropped out (27 in the experimental group and 15 in the control group). MEASUREMENTS: Individual behaviour and group behaviour were scored using two Dutch scales (BIP and SIPO respectively) developed and validated for use in psychogeriatric populations. Cognition was measured with the short and the long versions of the Cognitive Screening Test (CST-14 and CST-20). Disability was measured with the Barthel Index. Medicine use, falls, other accidents and life events were registered. RESULTS: The PAP had a beneficial effect on cognition (CST-14, F = 2.63, p < or = 0.05, effect size 0.4) (CST-20, F = 3.77, p < or = 0.05, effect size 0.5) and increased positive group behaviour in participants with relatively mild cognitive problems (SIPO, F = 4.46 p < or = 0.05). CONCLUSIONS: The PAP stabilizes cognitive performance and has some beneficial effects on behaviour. Positive findings were supported by a simultaneously conducted process evaluation.
Authors: Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland Journal: CNS Drugs Date: 2018-07 Impact factor: 5.749
Authors: Adam L Gordon; Phillipa A Logan; Rob G Jones; Calum Forrester-Paton; Jonathan P Mamo; John R F Gladman Journal: BMC Geriatr Date: 2012-06-25 Impact factor: 3.921
Authors: Ian D Cameron; Suzanne M Dyer; Claire E Panagoda; Geoffrey R Murray; Keith D Hill; Robert G Cumming; Ngaire Kerse Journal: Cochrane Database Syst Rev Date: 2018-09-07